An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA Gyrase Suppressive Features for The Treatment of Coronaviral & Adenoviral Infections NOVIR

Description

An Antiviral Formulation Consisting of 3 Protopanaxatriol-Class Glucopyranoside Analouges , A Semi-Synthetic Flavonol Glycoside Derivative and an Immuno-Modulatory Ginsenoside RG3 Subvariant for The Treatment of Coronaviral & Adenoviral Infections via Suppressing DNA Polymerase, RNA Dependent RNA Polymerase and Viral DNA Gyrase and Modulating Anti-Inflammatory Cytokines Tnf-Alpha, IL-6, Nf-Kappa B and PGE2 to Suppress Potential Cytokine Storms Simultaneously.

Inventors: ERDAL CAN ALKOCLAR & METEHAN YESIL

Producer

Latest update

April 21, 2020

License

Creative Commons Attribution 4.0

Metadata quality
44.0%

Files documentation missing

Update frequency not followed

File formats are closed

Temporal coverage not set

Spatial coverage not set

There are no reuses for this dataset yet.

Publish a reuse What's a reuse ?

There are no discussions for this dataset yet.

There are no community resources for this dataset yet.

Share your resources Learn more about the community

Information

Temporality

Creation

April 21, 2020

Frequency

Quarterly

Latest update

April 21, 2020

Actions

Embed